<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-SOA-2930</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2930</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Значение оценки воспалительных маркеров активации сосудистой стенки при возрастной макулярной дегенерации</article-title><trans-title-group xml:lang="en"><trans-title>Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8007-6643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балацкая</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Balatskaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Балацкая Наталья Владимировна – к.б.н., ведущий научный сотрудник, начальник отдела иммунологии и вирусологии </p><p>Москва</p></bio><bio xml:lang="en"><p>Balatskaya Natalia V., PhD (Biology), Leading Researcher, Head, Department of Immunology and Virology</p><p>Moscow</p></bio><email xlink:type="simple">balnat07@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9638-1147</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyova</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воробьева Елена Павловна – младший научный сотрудник отдела иммунологии и вирусологии </p><p>Москва</p></bio><bio xml:lang="en"><p>Vorobyova Elena P., Junior Researcher, Department of Immunology and Virology</p><p>Moscow</p></bio><email xlink:type="simple">helen1996@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1005-5633</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликова</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikova</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куликова Ирина Геннадьевна – биолог вирусологической микробиологической лаборатории отдела иммунологии и вирусологии </p><p>Москва</p></bio><bio xml:lang="en"><p>Kulikova Irina G., Biologist, Virology-Microbiology Laboratory, Department of Immunology and Virology</p><p>Moscow</p></bio><email xlink:type="simple">ig-kulikova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-2823-5297</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андрюшин</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Andryushin</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрюшин Александр Евгеньевич – научный сотрудник отдела иммунологии и вирусологии </p><p>Москва</p><p> </p></bio><bio xml:lang="en"><p>Andryushin Alexander E., Researcher, Department of Immunology and Virology</p><p>Moscow</p></bio><email xlink:type="simple">gradmalexander@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>07</day><month>07</month><year>2025</year></pub-date><volume>27</volume><issue>4</issue><fpage>863</fpage><lpage>872</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Балацкая Н.В., Воробьева Е.П., Куликова И.Г., Андрюшин А.Е., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Балацкая Н.В., Воробьева Е.П., Куликова И.Г., Андрюшин А.Е.</copyright-holder><copyright-holder xml:lang="en">Balatskaya N.V., Vorobyova E.P., Kulikova I.G., Andryushin A.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2930">https://www.mimmun.ru/mimmun/article/view/2930</self-uri><abstract><p>Среди многочисленных факторов патогенеза возрастной макулярной дегенерации (ВМД) в последние годы особое внимание уделяют эндотелиальной дисфункции (ЭД), поскольку эндотелий сосудов является важнейшим элементом внутренней области гематоретинального барьера (ВГРБ), обеспечивающему иммунологический гомеостаз сетчатки. Изучение воспалительных маркеров активации эндотелия представляется актуальным с целью понимания механизмов развития заболевания, может способствовать разработке патогенетической терапии ранней и промежуточной стадий ВМД, мер вторичной профилактики ее осложнений. Цель – определение sICAM-1, sVCAM-1, sE-selectin, sP-selectin и МСР-1/CCL2 в сыворотке крови (СК) и слезной жидкости (СЖ) пациентов с начальной (AREDS2) и промежуточной (AREDS3) стадиями ВМД. Исследование проведено методом проточной цитометрии (CBA) (проточный цитометр BD FACS Canto II, США) с помощью панели, сконструированной из совместимых симплексных тест-систем FlowCytomixTM (Bender MedSystem GmbH, Германия) для определения sICAM-1, sVCAM-1, sE-selectin, sP-selectin и МСР-1/CCL2, позволяющей осуществлять их одновременную детекцию, с обработкой данных в пакете FlowCytomix Pro v. 6.0 (BenderMed Systems GmbH, Германия). Выявлена тенденция к повышению уровня sVCAM-1 в СК пациентов группы с промежуточной ВМД по сравнению с нормой. При анализе системной продукции остальных маркеров не установлено различий между основными группами и возрастным контролем. В ходе исследования СЖ в группе AREDS2 обнаружено достоверное увеличение концентрации МСР-1/CCL2, sE-selectin (р &lt; 0,05) с тенденцией к усилению локальной продукции растворимых ICAM-1 и P-selectin (р = 0,05) относительно нормы. В группе AREDS3 значимые сдвиги касались 3 факторов sICAM-1, sE-selectin и sP-selectin, содержание которых в СЖ пациентов превышало таковое в контроле более чем в 2,5, почти в 5 и 2 раза соответственно (р &lt; 0,05). Выявлено преимущественно усиление локальной и в меньшей мере системной продукции маркеров, отражающее активированное состояние эндотелия. Полученные данные представляются важными, поскольку доказывают участие sICAM-1, sVCAM-1, sE-selectin, sP-selectin, МСР-1/CCL2 в патогенезе заболевания и позволяют думать о компроментации гематоретинального барьера, необходимости дополнения курса терапии ВМД назначением препаратов ангиопротекторного, противовоспалительного действия и нуждается в дальнейшем изучении.</p></abstract><trans-abstract xml:lang="en"><p>Among the numerous pathogenetic factors of age-related macular degeneration (AMD), special attention has been recently paid to endothelial dysfunction (ED), since the vascular endothelium is an important internal component of the the hematoretinal barrier (IBRB) providing immunological homeostasis of the retina. The study of inflammatory endothelial activation markers seems relevant in terms of understanding the mechanisms of disease development, potentially contributing to the development of pathogenetic therapy at early and intermediate stages of AMD as well as secondary prevention of its complications. The aim of the present: study was to determine sICAM-1, sVCAM-1, sE-selectin, sP-selectin and MCP-1/CCL2 in blood serum (BS) and tear fluid (TF) of patients with initial (AREDS2) and intermediate (AREDS3) stages of AMD. The study was performed by flow cytometry (CBA) with BD FACS Canto II flow cytometer, USA), using a diagnostic panel based on compatible simplex Flow CytomixTM test systems (Bender Med System GmbH, Germany) to determine sICAM-1, sVCAM-1, sE-selectin, sP-selectin and MCP-1/CCL2 thus allowing their simultaneous detection followed by data processing in the FlowCytomix Pro v. 6.0 package (BenderMed Systems GmbH, Germany). We have revealed a tendency to increased serum sVCAM-1 in the AREDS3 group compared to the reference values. When studying tear fluid in the AREDS2 group, a significant increase in MCP-1, sE-selectin concentrations was found (p &lt; 0.05), along with a tendency to increased local production of sICAM-1 and sP-selectin (p = 0.05) against normal levels. Significant shifts in the AREDS3 group concerned three 3 factors in tear fluid, i.e., sICAM-1, sE-selectin and sP-selectin, that exceeded control levels by 2.5, 5 and 2 times, respectively (p &lt; 0.05). The obtained data are important because they presume a role of sICAM-1, sVCAM-1, sE-selectin, sP-selectin, MCP-1/CCL2 in pathogenesis of the disorder and allows us to suggest a compromised state of blood retinal barrier, thus requiring supplementation of AMD therapy with angioprotectives, antiinflammatory drugs, and needs further studies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>возрастная макулярная дегенерация</kwd><kwd>дисфункция эндотелия сосудов</kwd><kwd>воспаление</kwd><kwd>маркеры</kwd><kwd>молекулы адгезии</kwd><kwd>хемокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>age-related macular degeneration</kwd><kwd>vascular endothelial</kwd><kwd>dysfunction</kwd><kwd>inflammation</kwd><kwd>markers</kwd><kwd>adhesion molecules</kwd><kwd>chemokines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Васина Л.В., Петрищев Н.Н., Власов Т.Д. Эндотелиальная дисфункция и ее основные маркеры // Регионарное кровообращение и микроциркуляция, 2017. Т. 16, № 1. С. 4-15.</mixed-citation><mixed-citation xml:lang="en">Vasina L.V., Petrishchev N.N., Vlasov T.D. Endothelial dysfunction and its main markers. Regionarnoye krovoobrashcheniye i mikrotsirkulyatsiya = Regional Blood Circulation and Microcirculation, 2017, Vol. 16, no. 1, pp. 4-15. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Балацкая Н.В., Нероева Н.В., Кармокова А.Г., Рябина М.В., Куликова И.Г. Скрининг цитокинов в сыворотке крови и слезной жидкости при влажной и атрофической формах возрастной макулярной дегенерации // Медицинская иммунология, 2022. Т. 24, № 1. С. 157-170. doi: 10.15789/1563-0625-SOC-2351.</mixed-citation><mixed-citation xml:lang="en">Neroev V.V., Balatskaya N.V., Neroeva N.V., Karmokova A.G., Ryabina M.V., Kulikova I.G. Screening of cytokines in blood serum and tear fluid in wet and atrophic forms of age-related macular degeneration. Meditsinskaya immunologiya = Medical Immunology (Russia), 2022, Vol. 24, no. 1, pp. 157-170. (In Russ.) doi: 10.15789/1563-0625-SOC-2351.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Пестрякова Я.Ф., Рыбченко А.А., Шабанов Г.А., Запорожец Т.С. Закономерности изменений биоэлектрической активности головного мозга при возрастной макулярной дегенерации // Тихоокеанский медицинский журнал, 2017. № 2. С. 26-29. doi: 10.17238/PmJ1609-1175.2017.2.26-29.</mixed-citation><mixed-citation xml:lang="en">Pestryakova Ya.F., Rybchenko A.A., Shabanov G.A., Zaporozhets T.S. Patterns of changes in bioelectrical activity of the brain during age-related macular degeneration. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2017, no. 2, pp. 26-29. (In Russ.) doi: 10.17238/PmJ1609-1175.2017.2.26-29.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of highdose supplementation with vitamins C and E, betacarotene, and zinc for age-related macular degeneration and vision loss: AREDS. Arch. Ophthalmol., 2001, Vol. 119, pp. 1417-1436.</mixed-citation><mixed-citation xml:lang="en">Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of highdose supplementation with vitamins C and E, betacarotene, and zinc for age-related macular degeneration and vision loss: AREDS. Arch. Ophthalmol., 2001, Vol. 119, pp. 1417-1436.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bhutto I.A., Baba T., Merges C., McLeod D.S., Lutty G.A. Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp. Eye Res., 2010, Vol. 90, no. 1, pp. 155-167.</mixed-citation><mixed-citation xml:lang="en">Bhutto I.A., Baba T., Merges C., McLeod D.S., Lutty G.A. Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp. Eye Res., 2010, Vol. 90, no. 1, pp. 155-167.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Binder F.P.C., Ernst B. E- and P-selectin: differences, similarities and implications for the design of P-selectin antagonists. Chimia (Aarau), 2011, Vol. 65, no. 4, pp. 210-213.</mixed-citation><mixed-citation xml:lang="en">Binder F.P.C., Ernst B. E- and P-selectin: differences, similarities and implications for the design of P-selectin antagonists. Chimia (Aarau), 2011, Vol. 65, no. 4, pp. 210-213.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Buschini E., Piras A., Nuzzi R., Vercelli A. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog. Neurogibol., 2011, Vol. 95, no. 1, pp. 14-25.</mixed-citation><mixed-citation xml:lang="en">Buschini E., Piras A., Nuzzi R., Vercelli A. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog. Neurogibol., 2011, Vol. 95, no. 1, pp. 14-25.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chaitanya G.V., Cromer W., Wells S., Jennings M., Mathis J.M., Minagar A., Alexander J.S. Metabolic modulation of cytokine-induced brain endothelial adhesion molecule expression. Microcirculation, 2012, Vol. 19, no. 2, pp. 155-165.</mixed-citation><mixed-citation xml:lang="en">Chaitanya G.V., Cromer W., Wells S., Jennings M., Mathis J.M., Minagar A., Alexander J.S. Metabolic modulation of cytokine-induced brain endothelial adhesion molecule expression. Microcirculation, 2012, Vol. 19, no. 2, pp. 155-165.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chakravarthy U., Wong T.Y., Fletcher A., Piault E., Evans C., Zlateva G., Buggage R., Pleil A., Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol., 2010, Vol. 10, 31. doi: 10.1186/1471-2415-10-31.</mixed-citation><mixed-citation xml:lang="en">Chakravarthy U., Wong T.Y., Fletcher A., Piault E., Evans C., Zlateva G., Buggage R., Pleil A., Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol., 2010, Vol. 10, 31. doi: 10.1186/1471-2415-10-31.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L. Risk factors for the incidence of Advanced Age–Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology, 2005, Vol. 112, no. 4, pp. 533-539.</mixed-citation><mixed-citation xml:lang="en">Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L. Risk factors for the incidence of Advanced Age–Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology, 2005, Vol. 112, no. 4, pp. 533-539.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Combadiere C., Potteaux S., Rodero M., Simon T., Pezard A., Esposito B., Merval R., Proudfoot A., Tedgui A., Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation, 2008, Vol. 117, no. 13, pp. 1649-1657.</mixed-citation><mixed-citation xml:lang="en">Combadiere C., Potteaux S., Rodero M., Simon T., Pezard A., Esposito B., Merval R., Proudfoot A., Tedgui A., Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation, 2008, Vol. 117, no. 13, pp. 1649-1657.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Du Z., Wu X., Song M., Li P., Wang L. Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD). Graefes Arch. Clin. Exp. Ophthalmol., 2016, Vol. 254, no. 12, pp. 2469-2476.</mixed-citation><mixed-citation xml:lang="en">Du Z., Wu X., Song M., Li P., Wang L. Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD). Graefes Arch. Clin. Exp. Ophthalmol., 2016, Vol. 254, no. 12, pp. 2469-2476.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dunbar H.M.P., Behning С., Abdirahman А., Higgins В.Е., Binns А.М., Terheyden J.H., Zakaria N., Poor S., Finger R.P., Leal S., Holz F.G., Schmid M., Crabb D.P., Rubin G.S., Luhmann U.F.O. Repeatability and discriminatory power of chart-based visual function tests in individuals with age-related macular degeneration: A MACUSTAR Study Report. JAMA Ophthalmol., 2022, Vol. 140, no. 8, pp. 780-789.</mixed-citation><mixed-citation xml:lang="en">Dunbar H.M.P., Behning С., Abdirahman А., Higgins В.Е., Binns А.М., Terheyden J.H., Zakaria N., Poor S., Finger R.P., Leal S., Holz F.G., Schmid M., Crabb D.P., Rubin G.S., Luhmann U.F.O. Repeatability and discriminatory power of chart-based visual function tests in individuals with age-related macular degeneration: A MACUSTAR Study Report. JAMA Ophthalmol., 2022, Vol. 140, no. 8, pp. 780-789.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Edlinger C., Lichtenauer M., Wernly B., Pistulli R., Paar V., Prodinger C., Krizanic F., Thieme M., Kammler J., Jung C., Hoppe U.C., Schulze P.C., Kretzschmar D. Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease. Heart Vessels, 2019, Vol. 34, no. 6, pp. 976-983.</mixed-citation><mixed-citation xml:lang="en">Edlinger C., Lichtenauer M., Wernly B., Pistulli R., Paar V., Prodinger C., Krizanic F., Thieme M., Kammler J., Jung C., Hoppe U.C., Schulze P.C., Kretzschmar D. Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease. Heart Vessels, 2019, Vol. 34, no. 6, pp. 976-983.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Horani М., Mahmood S., Aslam T.M. A review of macular atrophy of the retinal pigment epithelium in patients with neovascular age-related macular degeneration: What is the link? Part II. Ophthalmol. Ther., 2020, Vol. 9, no. 1, pp. 35-75.</mixed-citation><mixed-citation xml:lang="en">Horani М., Mahmood S., Aslam T.M. A review of macular atrophy of the retinal pigment epithelium in patients with neovascular age-related macular degeneration: What is the link? Part II. Ophthalmol. Ther., 2020, Vol. 9, no. 1, pp. 35-75.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hossain M., Qadri S.M., Liu L. Inhibition of nitric оxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. J. Inflamm. (Lond.), 2012, Vol. 9, 28. doi: 10.1186/1476-9255-9-28.</mixed-citation><mixed-citation xml:lang="en">Hossain M., Qadri S.M., Liu L. Inhibition of nitric оxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. J. Inflamm. (Lond.), 2012, Vol. 9, 28. doi: 10.1186/1476-9255-9-28.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Huang R.B., Gonzalez A.L., Eniola-Adefeso O. Laminar shear stress elicit distinct endothelial cell E-selectin expression pattern via TNFα and IL-1β activation. Biotechnol. Bioeng., 2013, Vol. 110, no. 3, pp. 999-1003.</mixed-citation><mixed-citation xml:lang="en">Huang R.B., Gonzalez A.L., Eniola-Adefeso O. Laminar shear stress elicit distinct endothelial cell E-selectin expression pattern via TNFα and IL-1β activation. Biotechnol. Bioeng., 2013, Vol. 110, no. 3, pp. 999-1003.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hudson N., Celkova L., Hopkins A., Greene C., Storti F., Ozaki E., Fahey E., Theodoropoulou S., Kenna P.F., Humphries M.M., Curtis A.M., Demmons E., Browne A., Liddie S., Lawrence M.S., Grimm C., Cahill M.T., Humphries P., Doyle S.L., Campbell M. Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. JCI Insight, 2019, Vol. 4, no. 15, e130273. doi: 10.1172/jci.insight.130273.</mixed-citation><mixed-citation xml:lang="en">Hudson N., Celkova L., Hopkins A., Greene C., Storti F., Ozaki E., Fahey E., Theodoropoulou S., Kenna P.F., Humphries M.M., Curtis A.M., Demmons E., Browne A., Liddie S., Lawrence M.S., Grimm C., Cahill M.T., Humphries P., Doyle S.L., Campbell M. Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. JCI Insight, 2019, Vol. 4, no. 15, e130273. doi: 10.1172/jci.insight.130273.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nian S., Lo A.C.Y., Mi Y., Ren K., Yang D. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis. (Lond.), 2021, Vol. 8, 15. doi: 10.1186/s40662-021-00239-1.</mixed-citation><mixed-citation xml:lang="en">Nian S., Lo A.C.Y., Mi Y., Ren K., Yang D. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis. (Lond.), 2021, Vol. 8, 15. doi: 10.1186/s40662-021-00239-1.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Schultz H., Song Y., Baumann B.H., Kapphahn R.J., Montezuma S.R., Ferrington D.A., Dunaief J.L. Increased serum proteins in non-exudative AMD retinas. Exp. Eye Res., 2019, 186, 107686. doi: 10.1016/j.exer.2019.05.026.</mixed-citation><mixed-citation xml:lang="en">Schultz H., Song Y., Baumann B.H., Kapphahn R.J., Montezuma S.R., Ferrington D.A., Dunaief J.L. Increased serum proteins in non-exudative AMD retinas. Exp. Eye Res., 2019, 186, 107686. doi: 10.1016/j.exer.2019.05.026.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D.O., Gerald F., Fowkes R. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation, 2005, Vol. 112, no. 7, pp. 976-983.</mixed-citation><mixed-citation xml:lang="en">Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D.O., Gerald F., Fowkes R. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation, 2005, Vol. 112, no. 7, pp. 976-983.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation, 2006, Vol. 113, pp. 2335-2362.</mixed-citation><mixed-citation xml:lang="en">Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation, 2006, Vol. 113, pp. 2335-2362.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wong W.L., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burdenprojection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health, 2014, Vol. 2, no. 2, pp. e106-e116.</mixed-citation><mixed-citation xml:lang="en">Wong W.L., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burdenprojection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health, 2014, Vol. 2, no. 2, pp. e106-e116.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Rev. Cardiovasc. Med., 2022, Vol. 23, no. 2, 73. doi: 10.31083/j.rcm2302073.</mixed-citation><mixed-citation xml:lang="en">Zhang J. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Rev. Cardiovasc. Med., 2022, Vol. 23, no. 2, 73. doi: 10.31083/j.rcm2302073.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
